Discover tanycytes in alzheimer's disease

Alzheimer's disease is often described as a problem of memory, but deep inside the brain, it is also a problem of cleanup. Scientists have now identified a surprising helper in that cleanup system: tiny cells called tanycytes. In a 2026 study by Sauvé and colleagues in Cell Press Blue, researchers found that these cells help move tau protein out of the fluid around the brain and into the bloodstream. A related Nature news report on the tanycyte and tau discovery explains why this matters for Alzheimer's disease.

What are tanycytes in Alzheimer's disease?

Tanycytes are special cells that line part of the brain called the third ventricle. They are unusual because they touch both the cerebrospinal fluid, or CSF, and blood vessels. That means they can act like tiny transport routes between the brain and the rest of the body.

Vincent Prévot, a neuroendocrinologist at Inserm in Paris and one of the researchers behind the work, describes them as highways for the brain. That idea fits well. If the brain is like a busy city, tanycytes may be some of the roads that carry waste away.

How tau protein builds up in Alzheimer's disease

Tau is a normal protein that helps support the inside of nerve cells. But in Alzheimer's disease, tau can change shape and become abnormal. When that happens, it can clump together into tangles. These tangles damage brain cells and are strongly linked to memory loss and thinking problems.

For years, scientists have known that tau builds up in the brain. What has been less clear is how the healthy brain tries to remove it. This new research suggests tanycytes are part of that answer.

How brain cells clear tau from cerebrospinal fluid

The team first studied tanycytes in lab experiments and found that the cells could take up tau and release it. Next, they injected human tau tagged with a fluorescent marker into the CSF of mice. This let them track where the protein traveled.

The result was striking. The tau showed up in tanycytes, then moved toward the pituitary gland and into the bloodstream. In other words, the cells seemed to carry tau out of the brain's fluid and toward the blood, where the body may be better able to deal with it.

This helps explain something many people wonder about: why blood tests for Alzheimer's can sometimes detect tau. If tau can be transported from CSF to blood, then blood biomarkers make more biological sense.

What the mouse and human data showed

When researchers impaired tanycytes in mice, tau built up more in the brain and less appeared in the blood. That strongly suggests these cells are important for tau clearance.

The scientists then looked at people. They compared CSF and blood samples from 86 people with Alzheimer's disease and 91 people without it. In people with Alzheimer's, less tau appeared to move from CSF into blood. One especially important form, called p-tau181, was lower in blood compared with CSF than expected. Since p-tau181 is closely associated with Alzheimer's disease, that finding caught attention.

The team also studied brain tissue after death. In people with Alzheimer's, many tanycytes looked damaged, broken, or fragmented. If these transport cells are injured, the brain may lose one of its ways to remove harmful tau.

Why this Alzheimer's discovery matters for diagnosis

This finding does not mean scientists have found a cure. But it does open useful new questions. Could doctors one day measure how well tanycytes are working? Could future treatments protect these cells or help them clear tau better? Could this improve blood testing for Alzheimer's?

Those ideas are still early. More studies are needed in larger groups of people, and researchers still need to understand whether tanycyte problems are a cause of disease, a result of disease, or both. Still, this is the kind of careful step that can improve diagnosis and, eventually, treatment.

For families, the practical message is simple: Alzheimer's is not caused by one thing. It involves many systems, including protein handling, brain cell health, and possibly these little transport cells. That is why progress often comes piece by piece.

What this means for future brain health research

This study is a good example of how science often advances. Researchers looked at a cell type that had not been studied much in Alzheimer's and found an important clue. It is also a reminder that the brain is connected to the whole body more than we once thought.

If you are interested in related brain research, Slothwise has a helpful explainer on how biological sex influences frontotemporal dementia symptoms and treatment. For a different example of how modern biology is speeding up discovery, there is also useful background on gene-edited animals made in one generation. These are not the original research sources here, but they offer extra context for curious readers following health AI, neuroscience, and the kind of science Slothwise often explains.

The big takeaway is hopeful but measured. Tanycytes may be part of the brain's waste-removal system, and when they fail, tau may build up more easily. That does not solve Alzheimer's yet, but it gives scientists a clearer map of what to study next.